Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70163 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Akram N Salah und 15 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Immunology Department, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, 11829, Cairo, Egypt. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Neoplasms, Autoimmune Diseases, Cardiovascular Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 286 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Monoclonal antibodies (mAbs) are a key class of biotherapeutic medicines used to treat a wide range of diseases, such as cancer, infectious diseases, autoimmune disorders, cardiovascular diseases, and hemophilia. They can be engineered for greater effectiveness and specific applications while maintaining their structural elements for immune targeting. Traditional immunoglobulin treatments have limited therapeutic uses and various adverse effects. That makes mAbs show rapid growth in the pharmaceutical market, with over 250 mAbs in clinical studies. Although mAbs offer higher specificity, they are less effective against complex antigens. They have become essential in treating diseases with limited medical options, providing innovative solutions that improve patients' quality of life through increasing survival rates, shortening the length of stay in hospitals with an improved treatment outcome, and reducing side effects. This review outlines the mechanisms, applications, and advancements of mAbs, highlighting their transformative role in modern medicine and their potential to shape future therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology and Immunology Department, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, 11829, Cairo, Egypt.
- Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Nasr City, 11884, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, University of Sadat City, Menofia, 32897, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Menoufia National University, km Cairo-Alexandria Agricultural Road, Menofia, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Heliopolis University, Cairo, 11785, Egypt.
- Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City, 11231, Cairo, Egypt.
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Salah, A. N., Hashem, A. H., Zaki, M. B., Abulsoud, A. I., Atta, A. M., Elkalla, W. S., Moustafa, H. A. M., El-Dakroury, W. A., El-Tokhy, F. S., ElBoghdady, J. A., Rizk, N. I., Abdel Mageed, S. S., Mohammed, O. A., Abdel-Reheim, M. A., Alghamdi, H. O., & Doghish, A. S. (2025). Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70163
Vancouver
Salah AN, Hashem AH, Zaki MB, Abulsoud AI, Atta AM, Elkalla WS, et al. Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70163
BibTeX
@article{Salah2025,
author = {Salah, Akram N and Hashem, Amr H and Zaki, Mohamed Bakr and Abulsoud, Ahmed I and Atta, Asmaa M and Elkalla, Wagiha S and Moustafa, Hebatallah Ahmed Mohamed and El-Dakroury, Walaa A and El-Tokhy, Fatma Sa'eed and ElBoghdady, Jasmine A and Rizk, Nehal I and Abdel Mageed, Sherif S and Mohammed, Osama A and Abdel-Reheim, Mustafa Ahmed and Alghamdi, Huda O and Doghish, Ahmed S},
title = {Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70163}
}
EUVIMED